Clinical Trial Update: AZD2066 Cocktail Study [Phase 1]

View source ↗

Summary

AZD2066 Cocktail, sponsored by AstraZeneca, has completed a Phase 1 trial evaluating its use for chronic pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• AZD2066 Cocktail (AZD2066)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Pain | Phase 1 | Status: COMPLETED